Abbott Gmbh & Co Kg

Basf Aktiengesellschaft

Abb Vie Deutschland Gmbh & Co. Kg

Abbott Laboratories Corporation

Abbvie Inc.

Knoll Aktiengesellschaft

Other

Abbott Gmbh & Co. Hg

Abbvie Deutschland Gmbh and Co Kg

Liliane Unger

Wolfgang Wernet

Andreas Haupt

Wilfried Martin Braje

Wilfried Lubisch

Karla Drescher

Wilfried Hornberger

Thorsten K Oost

Manfred Raschack

Karsten M Wicke

Andreas Kling

Wilhelm Amberg

Dagmar Klinge

Hartmut Riechers

Sean Colm Turner

Ernst Baumann

Astrid Netz

Hans-Juergen Teschendorf

Roland Grandel

Herve Geneste

Joachim Rheinheimer

Uwe Josef Vogelbacher

Gerd Steiner

Hervé Geneste

Udo Lange

Hans-Jurgen Teschendorf

Rainer Munschauer

Stefan Muller

Dorothea Starck

Hans-J&uuml;rgen Teschendorf

Frauke Pohlki

Daryl Richard Sauer

Gisela Backfisch

Ana Lucia Relo

Min Zhang

Hans-J&ouml;rg Treiber

Beate Hellendahl

Annegret Lansky

Anton Bespalov

Mario Mezler

Rainer Schlecker

Siegfried Bialojan

Beatrice Rendenbach-Mueller

Thomas Hoger

Stefan Hergenr&ouml;der

Matthias Mayrer

Berthold Behl

Ana-Lucia Relo

Rolf Jansen

Barbara Vogg

Juergen Delzer

Kai Blumbach

Barbara Neumann-Schultz

Andrea Hager-Wernet, Legal Representative

Sabine Schult

Jürgen Dinges

Laszlo Szabo

Christophe Henry

Rudolf Binder

Verena Baldinger

Armin Beyerbach

Stefan Blank

Robert Van Waterschoot

Dietmar Sch&ouml;bel

Charles W Hutchins

Josef Gries

Werner Seitz

Heinz Hillen

Hans P Hofmann

Katja Jantos

Yanbin Lao

Alfred Bach

Marcel Van Gaalen

Loic Laplanche

Thomas H&ouml;ger

Stefan M&uuml;ller

Torsten Arndt

Ana Lucia Jongen-Relo

Bernd Elger

Frieder Juchelka

Juliana Ruiz Caro

Stefan Hergenroder

Thomas Zierke

Claus Bollschweiler

Gerda Von Philipsborn

Georg Kettschau

Claus D Mueller

Franz Emling

Monika Knopp

Juergen Pfister

Hans-Jörg Treiber

Hans-Joerg Treiber

Hans J Treiber

Francisco Javier Garcia-Ladona

Hans-Peter Hofmann

Uta Holzenkamp

Oskar Ehrmann

Albrecht Franke, Deceased

Ferdinand Dengel

Kurt Schellhaas

The present invention relates to quinoline compounds of formula I wherein the variables are defined as in the claims and the description. The invention further relates to a pharmaceutical composition containing such compounds, to their use as modulators of the 5-HTreceptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of the 5-HTreceptor, and to methods for preventing or treating conditions and disorders which respond to the modulation of the 5-HTreceptor.

[object Object]

The present invention relates to novel substituted oxindole derivatives of formula (I), pharmaceutical compositions comprising them, and their use for the treatment of vasopressin-related disorders. 

Oxindole derivatives carrying an oxetane substituent and use thereof for treating vassopressin-related diseases

The present invention relates to novel 1,3-dihydroindol-2-one (oxindole) derivatives of the formula (I) in which

Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them

The present invention relates to novel 5,6-disubstituted oxindole derivatives and pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising such derivatives, and to the use of such derivatives for the manufacture of a medicament, and methods of treating disorders in a subject in need thereof, such as vasopressin-dependent disorders, using 5,6-disubstituted oxindole derivatives.

5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases

The present invention relates to novel carbamate-substituted oxindole derivatives, pharmaceutical compositions comprising them, and their use for the treatment of vasopressin-dependent disorders.

Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases

The present invention relates to novel amidomethyl-substituted oxindole derivatives, pharmaceutical compositions comprising them, and their use for the treatment of vasopressin-dependent disorders.

Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

The present invention relates to novel acylaminocycloalkyl compounds, in particular to the compounds of the formula I as described herein and to their salts and N-oxides. The compounds possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of the dopamine D3 receptor. In formula I, the variables have the following meanings:

Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor

The present invention relates to novel acylaminocycloalkyl compounds, in particular to the compounds of the formula I as described herein and to their salts and N-oxides. The compounds possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of the dopamine D3 receptor.

The present invention relates to novel substituted oxindole derivatives of formula (I), pharmaceutical compositions comprising them, and their use for the treatment of vasopressin-related disorders 

Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases

The present invention relates to novel substituted oxindole derivatives of the formula (I), pharmaceutical agents containing said derivatives, and the use thereof for the treatment of vasopressin-dependent illnesses.

Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

The present invention relates to novel 5-halogen-substituted oxindole derivatives, pharmaceutical compositions comprising them, and their use for the treatment of vasopressin-dependent disorders.

5-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseases

The invention relates to novel oxindole derivatives of general formula (I), wherein the substituents R, R, A, B, and Y are defined as in claim. The invention further relates to medicaments containing said derivatives, and use thereof for the prevention and/or treatment of vasopressin-dependent diseases. 

Substituted oxindole derivatives, medicaments containing said derivatives and use thereof

The present invention relates to aromatic compounds of the formula I wherein Ar is phenyl or an aromatic 5- or 6-membered C-bound heteroaromatic radical, wherein Ar may carry 1 radical Rand wherein Ar may also carry 1 or 2 radicals R; The invention also relates to the use of a compound of the formula I or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand.

Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

The present invention relates to novel oxindole derivatives of the general formula (I) to medicaments comprising them and to their use for the prophylaxis and/or treatment of diseases vasopressin dependent. 

Substituted oxindole derivatives and their use as vasopressin receptor ligands

Growing community of inventors

Ludwigshafen, Germany

Liliane Unger